Recall Atlas

Genentech recalls

2 official recalls and safety alerts involving Genentech since 2022-11, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Genentech or the relevant agency.

  1. 2024-06-05
  2. US
    Drugs & medicalClass II

    Genentech, Inc. recalls Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041-64

    Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.

    FDA · DrugGenentech, Inc.Nationwide within the United StatesOfficial notice →
  3. 2022-11-09
  4. US
    Drugs & medicalClass III

    Genentech Inc recalls Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing One Susvimo single-dose vial and One Susvimo initial fill…

    Defective Delivery System: Commercial implants do not meet the filed specification for the intended use, a few patients have experienced an issue with the implants that renders it non-functioning.

    FDA · DrugGenentech IncNationwide in the USAOfficial notice →